Reader sentiment, not investment advice. One vote per visitor; click again to change it.
Fresenius Medical Care stock (FMS) sits at $22.26, down 0.54% today. The business is worth $11.85B in the market, good for #791 of 800 on our coverage list.
The 52-week range is $19.25 to $26.58. Today's price is about 41% of the way from the low to the high.
Buyers are paying 11.8 times trailing earnings.
3 analysts follow the stock and the average call is "sell". The mean target, $23.57, sits 5.9% over where the stock trades.
This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.
Composite of 4 factors below, ranked against the 800 U.S. stocks BeStock covers.
Cheaper on P/E than most of BeStock’s coverage scores higher.
Higher trailing yield than most of BeStock’s coverage scores higher.
Trading closer to its 52-week high than most peers scores higher.
3 analysts, consensus Sell.
How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.
FMS is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.
Since 2020-07-06, the strategy has returned 1524.8% (321.7% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated weekly — not a guarantee of future results, and not a BeStock recommendation.
What Wall Street analysts and Morningstar's fair-value model expect for the stock
Wall Street’s average 12-month target is $23.57, 5.9% above today’s price, with a consensus rating of Sell.
Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.
Quote as of Oct 1, 2026 12:20 pm ET. Prices can lag the live tape. This is background information, not a recommendation.
Ranks are among the 800 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.
$22.26 is the latest print for FMS, a move of -0.54% against yesterday's close of $22.38. Today's low and high so far: $22.21 and $22.42.
Equity value comes to $11.85B at the current price. By that measure it is number 791 of the 800 names in our coverage.
Buyers pay 11.8 times the last twelve months of profit (EPS $1.90).
The year's floor is $19.25 and the ceiling $26.58. Shares are 16.2% away from that ceiling.
It does. Payouts over the past twelve months work out to a 3.84% yield; the latest ex-dividend date was May 22, 2026.
Of 3 analysts, 0% say buy, 67% hold and 33% sell. Price targets average $23.57, with the most cautious at $19.90 and the most optimistic at $25.80.
BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.
No comments yet — be the first to weigh in on FMS.